RESULTS Act Sign-On Letter
Click here for a PDF version of this letter.
November 19, 2025
The Honorable Mike Johnson
Speaker
U.S. House of Representatives
Washington, DC 20515
The Honorable John Thune
Majority Leader
U.S. Senate
Washington, DC 20510
The Honorable Hakeem Jeffries
Minority Leader
U.S. House of Representatives
Washington, DC 20515
The Honorable Charles Schumer
Minority Leader
U.S. Senate
Washington, DC 20510
Dear Senate Majority Leader Thune, Senate Minority Leader Schumer, Speaker of the House Johnson, and House Minority Leader Jeffries:
As organizations representing millions of patients and health care consumers— including individuals impacted by chronic conditions such as cancer, diabetes, kidney disease, autoimmune disorders, liver disease, lung disease, and other serious illnesses— we write to express our strong support for S. 2761 / H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
This bipartisan, bicameral legislation would make important reforms to the clinical laboratory payment system under Medicare to ensure our nation’s clinical laboratories continue to deliver routine testing services older people rely on every day, while striving to advance the next generation of diagnostics to improve and save lives.
Timely access to reliable and innovative clinical laboratory tests is critical to the prevention, early detection, therapy selection, and effective management of chronic and life-threatening diseases. For older Americans and those living with complex health conditions, clinical diagnostic tests are key to slowing progression, averting complications, and reducing hospitalizations.
In addition to generating critical, potentially life-changing insights, clinical laboratory testing provides tremendous value. Laboratory testing informs 70% of clinical decision making while spending under the clinical laboratory fee schedule represents less than 1% of total Medicare spending. But without Congressional action, Medicare reimbursement cuts—a fourth round of up to 15% on about 800 widely used tests—are scheduled to resume January 31, 2026. These drastic payment cuts threaten our nation’s clinical laboratories and could compromise patient access to necessary services and increase wait times for testing and results.
The RESULTS Act would establish a modernized, data-driven payment model that reflects commercial market rates, supports innovation, and ensures access to life- saving clinical diagnostic tests. Congress has acted to delay the next round of payment cuts for the last five years, but now is the time for permanent, sustained reform to provide long-term stability for the millions of Medicare beneficiaries and patients across the country whose health decisions rely on clinical laboratory results.
Access to timely and accurate diagnostic health information is not optional—it is foundational to the health and well-being of millions of Americans. On behalf of patients across the country, we urge you to move swiftly to pass the RESULTS Act.
Sincerely,
Alliance for Aging Research
Alliance for Patient Access
Alliance for Women’s Health and Prevention
American Sexual Health Association
Applied Pharmacy Solutions
Axis Advocates
Black Women’s Health Imperative
California Chronic Care Coalition
CancerCare
Caregiver Action Network
Center for Patient Advocacy Leaders
Cholangiocarcinoma Foundation
Chronic Care Policy Alliance
Community Liver Alliance
Family Heart Foundation
Gerontological Society of America
GO2 for Lung Cancer
Healthcare Institute of New Jersey
Healthy Women
ICAN, International Cancer Advocacy Network
LUNGevity Foundation
Lupus and Allied Disease Association, Inc.
Minority Health Institute, Inc.
The National Association of Directors of Nursing Administration
National Grange
National Health Council
Neuropathy Action Foundation
Partnership to Fight Chronic Disease
RetireSafe
Solve M.E.
